Cargando…
LZAP Inhibits p38 MAPK (p38) Phosphorylation and Activity by Facilitating p38 Association with the Wild-Type p53 Induced Phosphatase 1 (WIP1)
LZAP (Cdk5rap3, C53) is a putative tumor suppressor that inhibits RelA, Chk1 and Chk2 and activates p53. LZAP is lost in a portion of human head and neck squamous cell carcinoma and experimental loss of LZAP expression is associated with enhanced invasion, xenograft tumor growth and angiogenesis. p3...
Autores principales: | An, Hanbing, Lu, Xinyuan, Liu, Dan, Yarbrough, Wendell G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026010/ https://www.ncbi.nlm.nih.gov/pubmed/21283629 http://dx.doi.org/10.1371/journal.pone.0016427 |
Ejemplares similares
-
Clinical significance of Wip1 overexpression and its association with the p38MAPK/p53/p16 pathway in NSCLC
por: Yang, Shize, et al.
Publicado: (2017) -
WIP1 promotes cancer stem cell properties by inhibiting p38 MAPK in NSCLC
por: Deng, Kaiyuan, et al.
Publicado: (2020) -
Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope
por: Perfettini, Jean-Luc, et al.
Publicado: (2005) -
Wip1 phosphatase: between p53 and MAPK kinases pathways
por: Goloudina, Anastasia R., et al.
Publicado: (2016) -
Wip1 regulates SKOV3 cell apoptosis through the p38 MAPK signaling pathway
por: Feng, Yanping, et al.
Publicado: (2017)